Insidermedicine Daily News (Video)
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured ...
Insidermedicine is a daily health and medical video news service created by a leading physicians. Our content library contains videos in many languages including English, Chinese, Spanish, on over 100 different diseases. Joining the likes of the Associated Press and Reuters, Insidermedicine's newstories are featured by Google News and The News Room. April 25, 2007 Patients with HIV who are treated with protease inhibitors have an increased risk of heart attack, according to a study published in the New England Journal of Medicine. Combination antiretroviral therapy has had a dramatic effect in reducing illness and death associated with the HIV virus, however an earlier study showed that the risk of heart attacks increased by 17% with every year a patient spent on antiretroviral. It isn’t known, though, whether all antiretroviral drugs carry this risk. The assessment of the role of any specific drug is difficult because patients with HIV usually receive a combination of drugs, and often switch regimens because of the availability of newer substances, adverse events, or drug regimen failure. Previous studies have shown a relationship between the use of protease inhibitors, a class of antiretroviral drug, and cardiovascular disease, but there is little information on the risks associated with another class of antiretroviral therapy called nonnucleoside reverse-transcriptase inhibitors. In this study, more than 23,000 patients infected with the HIV virus were assessed to determine the incidence of heart attack and the association between heart attack and exposure to protease inhibitors or nonnucleoside reverse-transcriptase inhibitors. Confirming the earlier results, the researchers found the risk of having a heart attack increased by 16% per year of exposure to protease inhibitors alone, which is equal to twice the risk over five years. Not such effect was observed with nonnucleoside reverse-transcriptase inhibitors. It is thought that protease inhibitors raise the level of blood lipid, thereby increasing the risk of cardiovascular disease and heart attack. Patients treated with protease inhibitors should have their cholesterol and blood pressure levels monitored, and take steps to reduce their lifestyle-related risk factors. This includes maintaining a healthy weight, eating a low-fat diet rich in fruits in vegetables, and getting regular exercise. Reporting for Insidermedicine, I'm Dr. Susan Sharma.
Show all Visit Show Website http://www.insidermedicine.caRecently Aired
-
HD
Diabetes care has greatly improved in the past 20 years
(February 20, 2013 - Insidermedicine) From Maryland - Diabetes control ...
(February 20, 2013 - Insidermedicine) From Maryland - Diabetes control has greatly improved over the past 20 years, according to a report published in Diabetes Care. Researchers studied national health data from 1988-1994, and 1999-2010. They found that the number of diabetic patients who were able to meet or reach their goals of controlling A1C, blood pressure, and cholesterol, rose from about 2% to 19%.
-
HD
Children's body growth does not contribute to the development of myopia
(February 19, 2013 - Insidermedicine) From the UK - A ...
(February 19, 2013 - Insidermedicine) From the UK - A new report published in Ophthalmology finds that body stature growth during childhood does not appear to contribute to the development of near-sightedness (myopia). Researchers studied nearly 3,000 children taking part in a long-term study, investigating whether height and weight growth from birth to 10 years played a role in refractive errors and eye size at ages 11 and 15. Results showed that growth trajectories were associated with the scaling of eye size, but were only minimally associated with myopia
-
HD
Air pollution raises risk of dying after heart attack
(February 19, 2013 - Insidermedicine) From London - Air pollution ...
(February 19, 2013 - Insidermedicine) From London - Air pollution is associated with deaths after heart attacks, according to a report published in the European Heart Journal. Researchers reviewed over 150,000 patients who survived hospitalization for acute coronary syndrome, as well air pollution concentrations over a 6 year period. Participants were followed for an average of 3.7 years or until their death. Results showed that every 10µg/m3 increase air borne particulate matter raised death rates from ACS by 20%.
-
HD
Awareness of heart disease improving among women, but not enough
(February 19, 2013 - Insidermedicine) From New York - Women ...
(February 19, 2013 - Insidermedicine) From New York - Women are more aware of heart disease than ever before, but there is still much room for improvement, according to a report published in Circulation. Researchers surveyed over 1,200 women over the age of 25, and compared their answers to surveys from 1997, 2000, 2003, 2006 and 2009. Participants were asked about their lifestyle, their awareness of the leading cause of death among women, as well as whether they knew the warning signs of heart attack and what they would do if they experienced these symptoms. Results showed that 56% of women correctly identified heart disease as the leading killer among women--a twofold increase since 1997. However, only 36% of black women, 34% of Hispanic women and 44% of women aged 25-34 could correctly identify the disease as the leading cause of death among women. We spoke with Dr. Lori Mosca, principal investigator of this study, who offered some further insight.
-
HD
Income inequality strongly linked to hospital readmission
(February 15, 2013 - Insidermedicine) From Massachusetts - Income inequality ...
(February 15, 2013 - Insidermedicine) From Massachusetts - Income inequality is strongly associated with risk of hospital readmission, according to a report published in the BMJ. Researchers analyzed three years of Medicare data on all individuals aged 65 and older who had been hospitalized with heart attack, pneumonia, or heart failure. As well, researchers reviewed income inequality data from the US Census Bureau. Results of their analysis revealed that income inequality had no effect on 30-day mortality. However, those exposed to higher levels in inequality were significantly more likely to be readmitted to the hospital within 30 days.
-
HD
Plaque in arteries associated with AMD; Lung cancer to become leading cause of cancer death in Europe
(February 16, 2013 - Insidermedicine Week in Review) From Wisconsin ...
(February 16, 2013 - Insidermedicine Week in Review) From Wisconsin - Atherosclerosis may raise risk of early age-related macular degeneration, according to a report published in Ophthalmology. Researchers studied 1,700 individuals between 53 and 96 years of age. Participants were assessed for AMD at 5 year and 10 year followup, and intima-media thickness (IMT), plaque in the carotid artery, angina, MI or stroke were all reported by the patient's physician. Results showed that mean IMT was associated with early AMD and late AMD, but history of stroke, angina or MI had no such association. As well, the number of sites with plaque were linked to late AMD but not early AMD From Italy - Lung cancer will become the leading cause of death among women in Europe, according to a report published in the Annals of Oncology. Researchers examined cancer rates in the EU to estimate the amount of people that will die from the disease in 2013. They found that over 1.3 million Europeans will die from cancer in 2013. There will be an estimated 88,000 deaths from breast cancer and 82,000 from lung cancer. These lung cancer rates represent a 7% decline since 2009, while the breast cancer rates are declining. If these trends continue, researchers estimate that lung cancer will be the leading cause of cancer mortality in Europe by 2015.
-
HD
Many younger women have used the morning-after pill
(February 15, 2013 - Insidermedicine) From New Jersey - Nearly ...
(February 15, 2013 - Insidermedicine) From New Jersey - Nearly 1 in 10 younger women in the US have used the morning-after pill, according to a report released by the CDC. Researchers interviewed over 12,000 women, aged 15-44, from 2006-2010. They found that 1 in 9 younger women reported using the pill, and that 1 in 4 women in their early 20s used the pill at least once. Nearly 1 in 5 never-married women reported using the morning-after pill, while just 1 in 20 married women did so.
-
HD
Glaucoma patients do not perceive visual loss as a black tunnel
(February 15, 2013 - Insidermedicine) From London - A new ...
(February 15, 2013 - Insidermedicine) From London - A new report published in Ophthalmology examines how vision loss is perceived by glaucoma patients. Researchers studied 50 glaucoma patients, aged 52-82, with a wide range of visual field defects in both eyes. Participants underwent visual field testing, and were also shown several pictures and asked to select the image the best represented their perception of vision loss. None of the patients selected an image with a 'black tunnel' effect, or black patches. Rather, over 50% of the patients picked an imaged with blurred patches.
-
HD
Smoking bans reduce rates of premature birth
(February 14, 2013 - Insidermedicine) From Belgium – Efforts to ...
(February 14, 2013 - Insidermedicine) From Belgium – Efforts to ban smoking in public places have reduced rates of preterm birth, according to a report published in the BMJ. Researchers reviewed over 600,000 births over a 4 year period that saw the implementation of gradual smoking bans. Results showed that risk of preterm birth dropped after the introduction of new phase of the smoking bans. This association could not be explained by any other factor—including the mother’s age and socioeconomic status, and environmental factors such as pollution and influenza epidemics.
-
HD
Avastin combined with other cancer drug may stop spread of brain cancer
(February 14, 2013 - Insidermedicine) From Minnesota – Avastin combined ...
(February 14, 2013 - Insidermedicine) From Minnesota – Avastin combined with a cancer drug may stop brain cancer from spreading, according to a report published in PLOS ONE. Researchers studied a mouse model of brain cancer, administering bevacizumab alone, dasatinib alone, and a combo of the two drugs. They found that Avastin alone temporarily stopped the brain cancer but consequently encouraged the tumor to spread and become more aggressive. Use of both drugs, however, shrank the tumors and also stopped subsequent spread
